Simplex Trading’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8,176
| Closed | -$15.7K | – | 9159 |
|
|
2025
Q1 | $13K | Sell |
8,176
-17,617
| -68% | -$35.4K | ﹤0.01% | 6905 |
|
|
2024
Q4 | $47K | Buy |
25,793
+16,122
| +167% | +$71.4K | ﹤0.01% | 5930 |
|
|
2024
Q3 | $55K | Buy |
9,671
+6,617
| +217% | +$54.6K | ﹤0.01% | 5803 |
|
|
2024
Q2 | $24K | Sell |
3,054
-3,639
| -54% | -$38.3K | ﹤0.01% | 6735 |
|
|
2024
Q1 | $92K | Buy |
6,693
+5,745
| +606% | +$49.6K | ﹤0.01% | 5675 |
|
|
2023
Q4 | $5K | Buy |
+948
| New | +$4.68K | ﹤0.01% | 7862 |
|
|
2023
Q2 | – | Sell |
-3,189
| Closed | -$25.7K | – | 9422 |
|
|
2023
Q1 | $31K | Sell |
3,189
-752
| -19% | -$12.8K | ﹤0.01% | 6447 |
|
|
2022
Q4 | $73K | Buy |
3,941
+618
| +19% | +$14K | ﹤0.01% | 5427 |
|
|
2022
Q3 | $68K | Sell |
3,323
-1,234
| -27% | -$31.6K | ﹤0.01% | 6022 |
|
|
2022
Q2 | $94K | Buy |
4,557
+1,634
| +56% | +$46K | ﹤0.01% | 5636 |
|
|
2022
Q1 | $125K | Buy |
2,923
+1,332
| +84% | +$60K | ﹤0.01% | 5833 |
|
|
2021
Q4 | $95K | Buy |
+1,591
| New | +$127K | ﹤0.01% | 6334 |
|
|
2021
Q2 | – | Sell |
-478
| Closed | -$45.9K | – | 10337 |
|
|
2021
Q1 | $0 | Sell |
478
-1,200
| -72% | -$158K | ﹤0.01% | 9351 |
|
|
2020
Q4 | $178K | Buy |
1,678
+1,661
| +9,771% | +$221K | ﹤0.01% | 4769 |
|
|
2020
Q3 | $2K | Sell |
17
-1,521
| -99% | -$317K | ﹤0.01% | 7422 |
|
|
2020
Q2 | $497K | Buy |
1,538
+1,348
| +709% | +$216K | ﹤0.01% | 2917 |
|
|
2020
Q1 | $16K | Sell |
190
-1,820
| -91% | -$112K | ﹤0.01% | 6127 |
|
|
2019
Q4 | $79K | Buy |
2,010
+977
| +95% | +$29.4K | ﹤0.01% | 4748 |
|
|
2019
Q3 | $25K | Buy |
1,033
+724
| +234% | +$22K | ﹤0.01% | 5642 |
|
|
2019
Q2 | $10K | Sell |
309
-40
| -11% | -$1.59K | ﹤0.01% | 6107 |
|
|
2019
Q1 | $15K | Sell |
349
-245
| -41% | -$12.3K | ﹤0.01% | 5891 |
|
|
2018
Q4 | $28K | Buy |
+594
| New | +$36.1K | ﹤0.01% | 5044 |
|
|
2018
Q3 | – | Sell |
-456
| Closed | -$25.4K | – | 7703 |
|
|
2018
Q2 | $21K | Buy |
456
+216
| +90% | +$11.9K | ﹤0.01% | 5822 |
|
|
2018
Q1 | $13K | Sell |
240
-29
| -11% | -$1.57K | ﹤0.01% | 3782 |
|
|
2017
Q4 | $13K | Buy |
269
+151
| +128% | +$9.36K | ﹤0.01% | 3671 |
|
|
2017
Q3 | $8K | Buy |
118
+101
| +594% | +$7.52K | ﹤0.01% | 3992 |
|
|
2017
Q2 | $1K | Sell |
17
-12
| -41% | -$1.03K | ﹤0.01% | 5626 |
|
|
2017
Q1 | $2K | Sell |
29
-172
| -86% | -$13.7K | ﹤0.01% | 5270 |
|
|
2016
Q4 | $16K | Buy |
201
+24
| +14% | +$2.17K | ﹤0.01% | 3244 |
|
|
2016
Q3 | $19K | Buy |
+177
| New | +$19.6K | ﹤0.01% | 3023 |
|
|
2016
Q2 | – | Sell |
-48
| Closed | -$5.83K | – | 6097 |
|
|
2016
Q1 | $5K | Buy |
+48
| New | +$3.71K | ﹤0.01% | 4084 |
|
|
2015
Q4 | – | Sell |
-729
| Closed | -$58K | – | 5716 |
|
|
2015
Q3 | $50K | Buy |
+729
| New | +$63.5K | ﹤0.01% | 2000 |
|
|
2015
Q2 | – | Sell |
-513
| Closed | -$54.8K | – | 5475 |
|
|
2015
Q1 | $50K | Buy |
+513
| New | +$49.7K | 0.01% | 1568 |
|
Other funds holding INO
VCM
BCM
ACM
EP
Simplex Trading's INO Position: Q2 2025 in Review
Simplex Trading sold out of Inovio Pharmaceuticals (INO) in Q2 2025, closing a stake of 8,176 shares — an estimated $15.7K sold.
Simplex Trading first reported a position in INO in Q1 2015 and held it in 33 quarters. The position peaked at $497K in Q2 2020. 103 funds tracked by Wall St. Rank hold INO as of Q2 2025.
- Simplex Trading reported no remaining Inovio Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 8,176 Inovio Pharmaceuticals shares in Q2 2025, an estimated $15.7K.
- Simplex Trading first reported a position in Inovio Pharmaceuticals in Q1 2015 and held it in 33 quarters.
- Simplex Trading's Inovio Pharmaceuticals position peaked at $497K in Q2 2020.
- 103 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.